Farid Takes Helm of Aurion MAB - Takeaways - MDSpire

Farid Takes Helm of Aurion MAB

  • March 27, 2026

  • 2 min

Share

  • 1

    Marjan Farid has been appointed chair of Aurion Biotech's medical advisory board, focusing on vision restoration therapies.

  • 2

    Farid is a leading surgeon and clinical professor at the Gavin Herbert Eye Institute, UCI, specializing in cornea and cataract surgery.

  • 3

    Aurion is developing AURN001, an investigational cell therapy for corneal endothelial disease, currently in Phase 3 clinical trials.

  • 4

    In 2024, Aurion launched Vyznova, the first commercially available cell therapy for corneal endothelial disease.

  • 5

    Farid's expertise is expected to enhance Aurion's strategic direction and development of regenerative therapies for corneal disease.

Original Source(s)

Related Content